Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Italian Stock Exchange  >  Amplifon S.p.A.    AMP   IT0004056880

AMPLIFON S.P.A.

(AMP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Strengths
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • The stock is in a well-established, long-term rising trend above the technical support level at 24.95 EUR
Weaknesses
  • The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
  • The group shows a rather high level of debt in proportion to its EBITDA.
  • With an enterprise value anticipated at 5.46 times the sales for the current fiscal year, the company turns out to be overvalued.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 79.05 times its estimated earnings per share for the ongoing year.
  • The company is not the most generous with respect to shareholders' compensation.
Ratings chart
Sector Medical Equipment, Supplies & Distribution - Other
1st jan.Capitalisation (M$)Investor Rating
AMPLIFON S.P.A.-2.50%9 037
ABBOTT LABORATORIES4.78%196 561
MEDTRONIC PLC-0.20%157 350
BECTON, DICKINSON AND COMPA..4.00%75 691
HOYA CORPORATION-3.92%49 122
ALIGN TECHNOLOGY, INC.0.95%42 537
BAXTER INTERNATIONAL INC.-0.17%40 917
SARTORIUS STEDIM BIOTECH15.32%37 538
DEXCOM, INC.1.80%36 144
ZIMMER BIOMET HOLDINGS3.39%33 022
TERUMO CORPORATION-2.76%30 528
SYSMEX CORPORATION4.84%26 176
WEST PHARMACEUTICAL SERVICE..5.92%22 197
AMERISOURCEBERGEN CORPORATI..10.23%21 876
AVANTOR, INC.9.02%17 749
BIO-RAD LABORATORIES, INC.0.93%17 559
More Results
Financials
Sales 2020 1 562 M 1 900 M 1 900 M
Net income 2020 97,4 M 118 M 118 M
Net Debt 2020 1 071 M 1 303 M 1 303 M
P/E ratio 2020 79,1x
Yield 2020 0,27%
Capitalization 7 533 M 9 162 M 9 165 M
EV / Sales 2020 5,51x
EV / Sales 2021 4,54x
Nbr of Employees 11 003
Free-Float 53,2%
Upcoming event on AMPLIFON S.P.A.
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes